Incorporating Tumor Characteristics to Maximize 21-Gene Assay Utility: A Cost-Effectiveness Analysis.
- Overview
- Identity
- Additional Document Info
- View All
Overview
publication date
- January 2019
published in
has subject area
- Aged
- Antineoplastic Combined Chemotherapy Protocols
- Biomarkers, Tumor
- Breast Neoplasms
- Chemotherapy, Adjuvant
- Clinical Decision-Making
- Connecticut
- Cost-Benefit Analysis
- Decision Support Techniques
- Female
- Gene Expression Profiling
- Genetic Testing
- Humans
- Markov Chains
- Mastectomy
- Middle Aged
- Models, Statistical
- Neoplasm Recurrence, Local
- Prevalence
- Prognosis
- Quality-Adjusted Life Years
- Risk Assessment